Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease
Clinical trial NCT04049760 · COMPLETED
Trial details
- NCT number
- NCT04049760
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-11
- Primary completion
- 2024-11-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.